393
Views
0
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Systemic Tentacles of Chronic Obstructive Pulmonary Disease: Do We Need to Account for Renal Damage?

&

References

  • Bulcun E, Ekici M, Ekici A, Kisa U. Microalbuminuria in chronic obstructive pulmonary disease. COPD 2013; 10:186–192.
  • Chen CY, Hsu TW, Mao SJ, Chang SC, Yang PC, Lee YC, Yang KY. Abnormal renal resistive index in patients with mild-to-moderate Chronic Obstructive Pulmonary Disease. COPD 2013; 10:216–225.
  • Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137:831–837.
  • Mapel DW, Marton JP. Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD. Int J Chron Obstruct Pulmon Dis 2013; 8:127–134.
  • van Gestel YR, Chonchol M, Hoeks SE, Welten GM, Stam H, Mertens FW, van Domburg RT, Poldermans D. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant 2009; 24:2763–2767.
  • Evans RG, Goddard D, Eppel GA, O'Connor PM. Stability of tissue PO2 in the face of altered perfusion: a phenomenon specific to the renal cortex and independent of resting renal oxygen consumption. Clin Exp Pharmacol Physiol 2011; 38:247–254.
  • Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009; 24:97–106.
  • Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148:399–408.
  • Palm F, Nordquist L. Renal tubulointerstitial hypoxia: cause and consequence of kidney dysfunction. Clin Exp Pharmacol Physiol 2011; 38:474–480.
  • Haase VH. Hypoxia-inducible factor signaling in the development of kidney fibrosis. Fibrogen Tissue Repair 2012; 5 Suppl 1:S16.
  • Mirrakhimov AE. Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol 2012; 11:132.
  • Macnee W. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. Ann Med 2013; 45:291–300.
  • Sin DD, MacNee W. Chronic obstructive pulmonary disease and cardiovascular diseases: a “vulnerable” relationship. Am J Respir Crit Care Med 2013; 187:2–4.
  • Mirrakhimov AE, Mirrakhimov EM. Chronic obstructive pulmonary disease and vascular risk: should we account for diabetes mellitus and renal disease? Can J Cardiol 2013 May; 29:639. e9.
  • Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms. Chest 2013; 143:798–807.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.